All In Biotech

Drug Trial Radar · NCT06162611

Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo

Generating Evidence to Improve Same-day Etonogestrel (ENG) Implant Insertion for Emergency Contraception

Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 790 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

790

Planned (sponsor's estimate)

Start

Nov 6, 2023

Primary completion

Apr 30, 2028

Study completion May 31, 2028

Sponsor

Lead sponsor
Lori GawronAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Planned Parenthood Association of Utah
First posted
Dec 8, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 35 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Intrauterine devices (IUDs) are highly effective to prevent pregnancy when used for emergency contraception (following unprotected intercourse in the last 3 days), but data are lacking for people who desire an etonogestrel (ENG) contraceptive implant in this situation. This proposal will identify the most effective way to start an implant for emergency contraception using a randomized controlled trial comparing pregnancy risk between those receiving the implant vs. the implant plus oral emergency contraception (EC). Data from this project will inform clinical practice and add another option, the implant, for those desiring a long acting, highly effective contraceptive method when they present for emergency contraception.

Conditions

  • Emergency Contraception

Interventions

  • Etonogestrel implant with Oral Levonorgestrel emergency contraception 1.5mgDrug

    Single pill of oral levonorgestrel 1.5mg X 1 dose (e.g. Plan B) same day as contraceptive implant insertion

  • Etonogestrel implant with oral placeboDevice

    Single pill of placebo same day as contraceptive implant insertion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of the etonogestrel contraceptive implant with placebo for emergency contraceptionTime frame: 1 month after enrollment
  2. Efficacy of the etonogestrel contraceptive implant with placebo for emergency contraception by BMI categoryTime frame: 1 month after enrollment
  3. Efficacy of the etonogestrel contraceptive implant with oral levonorgestrel for emergency contraceptionTime frame: 1 month after enrollment
  4. Efficacy of the etonogestrel contraceptive implant with oral levonorgestrel for emergency contraception by BMI categoryTime frame: 1 month after enrollment
  5. Ovulation frequency within 5 days of implant insertion in the oral levonorgestrel armTime frame: 5 days after implant insertion
  6. Ovulation frequency within 5 days of implant insertion in the placebo armTime frame: 5 days after implant insertion

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Planned Parenthood Association of Utah

    Salt Lake City, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.